LPL Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
VCM
BTW
LPL Financial's AMPH Position: Q1 2026 in Review
LPL Financial sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 19,844 shares — an estimated $531K sold.
LPL Financial first reported a position in AMPH in Q2 2019 and held it in 12 quarters. The position peaked at $2.13M in Q1 2022. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- LPL Financial reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- LPL Financial sold 19,844 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $531K.
- LPL Financial first reported a position in Amphastar Pharmaceuticals in Q2 2019 and held it in 12 quarters.
- LPL Financial's Amphastar Pharmaceuticals position peaked at $2.13M in Q1 2022.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.